Articles From: GSE Reports Second Quarter 2013 Results to GSK Gets Positive EU Opinion for Cervarix Vaccine 2-Dose Schedule


HOUSTON , Aug.
Sign-up for GSE Reports Second Quarter 2013 Results investment picks
2013/11/15
HOUSTON , Nov.
Sign-up for GSE Reports Third Quarter 2013 Results investment picks
2014/3/17
GSI Group Announces Closing of JADAK LLC Acquisition Canada NewsWire BEDFORD, Mass.
Sign-up for GSI Group Announces Closing of JADAK LLC Acquisition investment picks
2014/3/17
BEDFORD, Mass.
Sign-up for GSI Group Announces Closing of JADAK LLC Acquisition investment picks
2014/3/11
- Fourth Quarter 2013 Revenue of $88 million, 32% year-over-year growth - Fourth Quarter 2013 Adjusted EBITDA of $13.7 million - Fourth Quarter 2013 Non-GAAP Earnings Per Share of $0.18 - Full Year Revenue of $342 million, 26% year-over-year growth - Full Year Adjusted EBITDA of $51 million BEDFORD, Mass.
Sign-up for GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2013 investment picks
GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2013 Canada NewsWire - Fourth Quarter 2013 Revenue of $88 million , 32% year-over-year growth - Fourth Quarter 2013 Adjusted EBITDA of $13.7 million - Fourth Quarter 2013 Non-GAAP Earnings Per Share of $0.18 - Full Year Revenue of $342 million , 26% year-over-year growth - Full Year Adjusted EBITDA of $51 million BEDFORD, Mass.
Sign-up for GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2013 investment picks
2013/8/6
-- Second Quarter 2013 Revenue of $85 million --
Sign-up for GSI Group Announces Financial Results for the Second Quarter 2013 investment picks
GSI Group Announces Financial Results for the Second Quarter 2013 Canada NewsWire BEDFORD, Mass.
Sign-up for GSI Group Announces Financial Results for the Second Quarter 2013 investment picks
GSI Group Announces Financial Results for the Third Quarter 2013 Canada NewsWire --
Sign-up for GSI Group Announces Financial Results for the Third Quarter 2013 investment picks
2013/11/5
-- Third Quarter 2013 Revenue of $85.5 million, 23% year-over-year growth --
Sign-up for GSI Group Announces Financial Results for the Third Quarter 2013 investment picks
2014/1/28
GSI Group Inc. Schedules Earnings Release and Conference Call for Tuesday, March 11, 2014 Canada NewsWire BEDFORD, Mass.
Sign-up for GSI Group Inc. Schedules Earnings Release and Conference Call for Tuesday, March 11, 2014 investment picks
2014/1/28
BEDFORD, Mass.
Sign-up for GSI Group Inc. Schedules Earnings Release and Conference Call for Tuesday, March 11, 2014 investment picks
GSI Group Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2013 Canada NewsWire BEDFORD, Mass.
Sign-up for GSI Group Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2013 investment picks
2013/10/9
BEDFORD, Mass.
Sign-up for GSI Group Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2013 investment picks
2014/2/18
GSI Group to acquire JADAK Technologies Inc. for $93.5 Million in Cash Canada NewsWire BEDFORD, Mass.
Sign-up for GSI Group to acquire JADAK Technologies Inc. for $93.5 Million in Cash investment picks
2014/2/18
BEDFORD, Mass.
Sign-up for GSI Group to acquire JADAK Technologies Inc. for $93.5 Million in Cash investment picks
Grain Systems, Inc. (GSI), a global brand of AGCO (NYSE: AGCO), announced today that it has purchased Johnson System Inc. (JSI), a leading manufacturer of catwalks, towers and support structures based in Marshall, Michigan.
Sign-up for GSI Purchases Johnson System Inc. (JSI), a Leading Manufacturer of Catwalks, Towers, Support Structures investment picks
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1044881&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for GSI Technology, Inc. Announces Stock Repurchase Program investment picks
2013/10/31
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1064307&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. Reports Second-Quarter Fiscal 2014 Results investment picks
2014/1/30
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1086030&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. Reports Third-Quarter Fiscal 2014 Results investment picks
2013/10/22
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1061573&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. to Announce Fiscal 2014 Second-Quarter Results on October 31, 2013 investment picks
2014/1/24
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1084469&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. to Announce Fiscal 2014 Third-Quarter Results on January 30, 2014 investment picks
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1080791&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. to Present at 16th Annual Needham Growth Conference investment picks
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1070208&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. to Present at the LD MICRO Sixth Annual Conference investment picks
2013/12/17
Company Announcement Arzerra(r) receives Priority Review from FDA PDUFA date of April 19, 2014 COPENHAGEN, Denmark, Dec.
Sign-up for GSK and Genmab Receive Priority Review from FDA for Arzerra(r) (ofatumumab) as 1st Line Treatment for Chronic Lymphocytic Leukemia (CLL) investment picks
LONDON and LEIDEN, Netherlands, Sept.
Sign-up for GSK and Prosensa Announce Primary Endpoint Not Met in Phase III Study of Drisapersen in Patients With Duchenne Muscular Dystrophy investment picks
2013/12/6
http://media.marketwire.com/attachments/201310/67907_gsk_logo.gif http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1074343&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA --
Sign-up for GSK and Theravance Announce Positive Results From Pivotal Phase III Study for Fluticasone Furoate/Vilanterol in Asthma investment picks
LONDON--GlaxoSmithKline PLC (GSK.LN) Tuesday announced top-line results from the Phase III STABILITY trial, as part of its continuing effort to investigate the role of Lp-PLA2 inhibition in coronary heart disease and other diseases.
Sign-up for GSK Announces Top-Line Results from Phase III Study of Darapladib investment picks
- First approved combination of oral targeted therapies for unresectable or metastatic melanoma with BRAF V600E or V600K mutations[1] LONDON , Jan.
Sign-up for GSK gains accelerated FDA approval for combination use of Mekinist® (trametinib) and Tafinlar® (dabrafenib) investment picks
By Tapan Panchal LONDON--GlaxoSmithKline PLC (GSK.LN) said Thursday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended marketing authorization for a two-dose schedule for its cervical cancer vaccine, Cervarix, in girls aged nine to 14 years.
Sign-up for GSK Gets Positive EU Opinion for Cervarix Vaccine 2-Dose Schedule investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: GSE Reports Second Quarter 2013 Results to GSK Gets Positive EU Opinion for Cervarix Vaccine 2-Dose Schedule
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity